Your browser doesn't support javascript.
loading
Regulatory gene mutations affecting apolipoprotein gene expression: functions and regulatory behavior of known genes may guide future pharmacogenomic approaches to therapy.
Zannis, Vassilis I; Liu, Tong; Zanni, Markella; Kan, Horng-Yuan; Kardassis, Dimitris.
Afiliación
  • Zannis VI; Section of Molecular Genetics, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA. vzannis@bu.edu
Clin Chem Lab Med ; 41(4): 411-24, 2003 Apr.
Article en En | MEDLINE | ID: mdl-12747582
A pharmacogenomic approach to therapy requires systematic knowledge of the regulatory regions of the genes, as well as basic understanding of transcriptional regulatory mechanisms of genes. Using the apolipoprotein (apo) A-I/CIII gene cluster as a model system, we have identified by in vitro and in vivo studies the regulatory elements and the factors which control its transcription. Studies in transgenic mice established that the hepatocyte nuclear factor (HNF-4) binding site of the apoCIII enhancer, which controls transcription of both genes, is required for the intestinal expression of apoA-I and apoCIII genes, and enhances synergistically their hepatic transcription in vivo. The three Sp1 sites of the enhancer are also required for the intestinal expression of apoA-land apoCIII genes in vivo, and for the enhancement of the hepatic transcription. The regulation of the apoE/apoCI/apoCIV/apoCII cluster is also cited. It is expected that identification of the regulatory regions of genes will be soon accelerated by the sequencing of several mammalian genomes. The functional analyses of the regulatory domains of genes involved in lipid homeostasis, combined with cross-species sequence comparisons in the near future, may identify natural regulatory gene polymorphisms in the general population that will permit rational pharmacogenomic approaches for treatment of dyslipidemias.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Apolipoproteínas C / Regulación de la Expresión Génica / Apolipoproteína A-I / Proteínas de Unión al ADN / Mutación Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Clin Chem Lab Med Asunto de la revista: QUIMICA CLINICA / TECNICAS E PROCEDIMENTOS DE LABORATORIO Año: 2003 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Alemania
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Apolipoproteínas C / Regulación de la Expresión Génica / Apolipoproteína A-I / Proteínas de Unión al ADN / Mutación Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Clin Chem Lab Med Asunto de la revista: QUIMICA CLINICA / TECNICAS E PROCEDIMENTOS DE LABORATORIO Año: 2003 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Alemania